Melatonin May Lower Self-Harm Risk in Young People, Especially Girls
A observational study found the risk of self-harm increased in the months preceding melatonin prescription and decreased thereafter.
A observational study found the risk of self-harm increased in the months preceding melatonin prescription and decreased thereafter.
Investigators affiliated with Avadel Pharmaceuticals plc published a paper describing the risk of accidental dosing errors with oxybate.
The randomized, placebo-controlled segment of the study showed that AD109 had a statistically significant and clinically meaningful difference from placebo after a single dose in the patients’ hypoxic burden.
Twenty percent of restless legs syndrome patients are already on higher-than-recommended doses of dopamine agonists, says John Winkelman, MD, PhD.
Read MoreThe acquisition of Sunosi adds a high-potential commercial asset to Axsome’s late-stage neuroscience portfolio.
Read MoreAzurity Pharmaceuticals Inc has acquired Arbor Pharmaceuticals Inc, marketers of the restless legs syndrome drug Horizant.
Read MorePrevious studies completed by the UB researchers found that the NSAIDs ibuprofen and ketoprofen also affected the movement of GHB in the body.
Read MoreOptumRx will offer and administer standard pharmacy benefit coverage for members who choose to add the product to their formularies.
Read MoreBenzodiazepines, including brand names such as Restoril, Ativan, and Halcion and the “z-drugs”, a type of medication known more commonly under names like Ambien, Lunesta, and Sonata, are among the most frequently prescribed medications for older adults.
Read MoreServe You Rx will provide prescription benefit coverage of Somryst to their members as a standard offering on all formularies.
Read MoreThe FDA also published its summary of clinical superiority findings for Xywav for the treatment of cataplexy or excessive daytime sleepiness associated with narcolepsy.
Read More“As some adult patients with ADHD experience insomnia, there is considerable individual variability, and an identified need for more data on the effect of prescription ADHD stimulant medications on sleep.”
Read More“The analyses include both a traditional approach to presenting efficacy data, as well as one that underscores the clinical relevance of the findings, using [number needed to treat] and effect sizes to capture overall clinical benefit.”
Read MoreThirteen abstracts sponsored by Jazz Pharmaceuticals and five abstracts from investigator-sponsored trials will be presented at SLEEP 2021.
Read MoreThere was no difference in sleep quality or duration between those who did and didn’t take these meds for 1 to 2 years, the findings show.
Read MoreSleep disorders are highly comorbid with a multitude of psychiatric disorders and narcolepsy can have a significant impact on a person’s daily functioning, which may greatly affect their social, emotional and psychological well-being, and quality of life.
Read MoreThe AAN presentation further quantifies the previously reported Phase 3 top-line results.
Read MoreMany commonly prescribed drugs—such as some sleep aids—are known to carry an increased risk of breaking a bone, by increasing falls, weakening bones, or both.
Read More